Global Classical Swine Fever Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Scope of the Report:
In the last several years, global market of Classical Swine Fever Vaccines developed steadily, with an average growth rate of 5%. In 2017, global sales revenue of Classical Swine Fever Vaccines is nearly 140 M USD; the actual sale is about 4.21 billion doses.
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2017 is about 60.7%. And the proportion of Cell Line Origin in 2016 is about 39.3%.
Classical Swine Fever Vaccines is application in Government Tender and Market Sales. The most of Classical Swine Fever Vaccines Are Market Sales, and the market share in 2017 is about 95.1%.
The worldwide market for Classical Swine Fever Vaccines is expected to grow at a CAGR of roughly 3.8% over the next five years, will reach 180 million US$ in 2024, from 150 million US$ in 2019, according to a new study.
This report focuses on the Classical Swine Fever Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tissue Culture Origin
Cell Line Origin

Market Segment by Applications, can be divided into
Government Tender
Market Sales

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales, revenue and global market share of Classical Swine Fever Vaccines in 2017 and 2018.
Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Classical Swine Fever Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions